14 research outputs found
Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
The COVID-19 pandemic has made evident the need to develop effective strategies to
cushion the psychological consequences of social catastrophes. Preliminary evidence suggests that
the use of hallucinogens is a protective factor that mitigates against such stressors. However, the
underlying mechanisms must be further explored. This study specifically focused on the potential
role of coping strategies in this regard, analyzing them through an online survey completed by a total
of 2971 subjects who were followed up with from the beginning of the COVID-19 pandemic until six
months after baseline. The survey was published in three different cultures (English, Spanish, and
Portuguese), allowing for the collection of data from three different cultural contexts. The results show
that coping strategies were generally more related to psychological well-being and psychopathology
than to hallucinogenic drug use. However, regarding the latter, users of hallucinogens had higher
scores on problem-focused engagement and disengagement and lower scores on wishful thinking
than non-users. Longitudinally, while most baseline coping scores were associated with psychological
distress and the severity of psychological symptoms, some coping strategies were related to the use
of hallucinogens. These results show an adaptive pattern of coping strategies among hallucinogen
users. Further research should take into account that coping strategies are only marginally associated
with hallucinogenic drug use. Other underlying mechanisms explaining the better adjustment of
users of hallucinogens to pandemics should be explore
An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers
Therapeutic properties of ibogaine in the treatment of addiction are attracting both clinicians and patients to its use. Since ibogaine is not an authorized medicine, the quality of these products is not always known, increasing the probability of adverse reactions. Objective: This study collects different types of iboga-derived samples from treatment providers, vendors and online buyers to analyse their content. Methods: Analysis of iboga products (n = 16) was performed using gas chromatography and mass spectrometry methods (GC/MS). Products included Iboga root bark, Total Alkaloids (TA), Purified Total Alkaloids (PTA HCl), ibogaine hydrochloride (ibogaine HCl) and one Voacanga africana root bark. Results: The content of ibogaine was highly variable, ranging from 0.6% to 11.2% for products sold as iboga root bark, from 8.2% to 32.9% for products sold as TA, 73.7% for one sample sold as PTA and from 61.5% to 73.4% for products sold as ibogaine HCl. One sample did not show any iboga alkaloids. Other alkaloids and unknown substances were found in almost all samples. Discussion: The purity of iboga products is highly variable. These results should be taken into consideration by suppliers and users, especially regarding correct dosing to avoid overdose, as well as potential interactions with other substances
Psychedelic assisted psychotherapy configuration
El siguiente informe tiene la intención de detallar algunos de los puntos más importantes a tener en cuenta a la hora de cimentar las bases de la aplicación clínica de la psicoterapia asistida con sustancias psicodélicas. Citando los puntos más importantes a tener en cuenta, se propondrá un marco idóneo para el correcto desarrollo de la psicoterapia asistida con sustancias psicodélicas, partiendo de la asunción de que ésta cuenta con determinadas características especiales que deben
ser cuidadosamente atendidas y respetadas.The purpose of this report is to provide some of the most important factors of the clinical application of the psychedelic-assisted psychotherapy. Remembering the most important considerations of this treatment, we will expose the basic conditions for his construction. This treatment has some special features, which we have to respect in detail.info:eu-repo/semantics/publishedVersio
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Psychometric properties of plutchik's impulsivity scale in juvenile Spanish-speaking population
Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: A transcultural study
Background: One of the main public health strategies adopted at the beginning of the COVID-19 pandemic consisted of implementing strict lockdowns to stop the transmission of the virus. Despite being an effective measure, the confinement and the associated social isolation create a stressful, potentially lengthy situations that has been proven to have several psychological consequences. Given the potential benefits that certain psychedelic drugs have shown for the treatment of psychological disorders, this study aimed to assess the impact of lifetime psychedelic drug use on mental health in relation to the first strict lockdown adopted by various countries (April-July 2020). Methods: Subjects completed an online survey that inquired about sociodemographic factors, activities, and lifestyle factors during confinement, as well as health and mental health related factors. Subjects were asked about their lifetime use of psychedelic drugs (MDMA, ayahuasca, psilocybin-containing mushrooms, LSD, peyote, San Pedro, Bufo alvarius or 5-MeO-DMT, and others), being classified as regular users (more than once per 6 months), occasional users, or non-users. The survey included psychometric tests used to assess psychological distress, peritraumatic stress, social support, psychopathological symptoms, and personality. Linear regressions were performed with psychedelic drug users as the independent variable and psychometric factors as the outcomes, while correcting for age, gender, language, religion, spirituality, and use of non-psychedelic drugs. Results: The study included 2,974 English, Portuguese, and Spanish speakers (497 regular users of psychedelic drugs, 606 occasional users, and 1,968 non-users). On average, respondents were 36 years old and 70% were female. Psychedelic drug users, especially regular ones, reported less psychological distress, less peritraumatic stress, and more social support. Regarding personality measures, psychedelic drug users scored higher on the novelty-seeking and self-transcendence scales, and lower on cooperativeness. Conclusion: Our findings showed that regular users of psychedelic drugs had less psychological stress and some personality differences when compared to occasional users and non-users. This suggests that either the use of psychedelics might be a protective factor itself or people with certain previous traits are more prone to frequently using psychedelic drugs. Future prospective longitudinal research should investigate the underlying processes observed in this study to develop consistent hypothese